Coronavirus Nucleocapsid 兔单抗（Anti-SARS）

1, Al-Dalahmah O, et al. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage.Acta neuropathologica communications, PubMed ID: 32847628
2, Matschke J, et al. Neuropathology of patients with COVID-19 in Germany: a post-mortem case series.The Lancet. Neurology, PubMed ID: 33031735
3, Jacob F, et al. Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium.Cell stem cell, PubMed ID: 33010822
4, Szabolcs M, et al. Identification of Immunohistochemical Reagents for In Situ Protein Expression Analysis of Coronavirus-associated Changes in Human Tissues.Applied immunohistochemistry & molecular morphology : AIMM, PubMed ID: 33086222
5, Andrews MG, et al. Tropism of SARS-CoV-2 for Developing Human Cortical Astrocytes.bioRxiv : the preprint server for biology, PubMed ID: 33469577
6, Putcharoen O, et al. Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand.PloS one, PubMed ID: 33577615
7, Xu X, et al. Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study.Signal transduction and targeted therapy, PubMed ID: 34006847
8, Bennett RS, et al. Scalable, Micro-Neutralization Assay for Assessment of SARS-CoV-2 (COVID-19) Virus-Neutralizing Antibodies in Human Clinical Samples.Viruses, PubMed ID: 34065987
9, Renuse S, et al. A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens.EBioMedicine, PubMed ID: 34229274
10, Avendaño-Ortiz J, et al. SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19.Journal of immunology (Baltimore, Md. : 1950), PubMed ID: 34183364
11, Kudose S, et al. Longitudinal Outcomes of COVID-19-Associated Collapsing Glomerulopathy and Other Podocytopathies.Journal of the American Society of Nephrology : JASN, PubMed ID: 34670811
12, Duan X, et al. An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection.Cell reports, PubMed ID: 34731648
13, Bennett RP, et al. Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties.JCI insight, PubMed ID: 34807849
14, Maus A, et al. Targeted Detection of SARS-CoV-2 Nucleocapsid Sequence Variants by Mass Spectrometric Analysis of Tryptic Peptides.Journal of proteome research, PubMed ID: 34779632
15, Golden JW, et al., PubMed ID: 35073750
16, Li Z, et al. Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry.Cell metabolism, PubMed ID: 35150639
17, Mizutani M, et al. Pathologic and Neuropathologic Study of a Case of COVID-19.JMA journal, PubMed ID: 35224283
18, Tomris I, et al. Distinct spatial arrangements of ACE2 and TMPRSS2 expression in Syrian hamster lung lobes dictates SARS-CoV-2 infection patterns.PLoS pathogens, PubMed ID: 35255100
19, Wang Z, et al. SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies.Signal transduction and targeted therapy, PubMed ID: 35461307
20, Chong Z, et al. Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron.bioRxiv : the preprint server for biology, PubMed ID: 35118466
21, Zheng H, et al. Longitudinal analyses reveal distinct immune response landscapes in lung and intestinal tissues from SARS-CoV-2-infected rhesus macaques.Cell reports, PubMed ID: 35594870
22, Chong Z, et al. Nasally delivered interferon-λ protects mice against infection by SARS-CoV-2 variants including Omicron.Cell reports, PubMed ID: 35523172
23, Rosendal E, et al. Serine Protease Inhibitors Restrict Host Susceptibility to SARS-CoV-2 Infections.mBio, PubMed ID: 35532162
24, Nicholson MW, et al. Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs.Pharmaceuticals (Basel, Switzerland), PubMed ID: 35745684
25, Wang L, et al. SARS-CoV-2 ORF10 impairs cilia by enhancing CUL2ZYG11B activity.The Journal of cell biology, PubMed ID: 35674692
26, Vanderboom PM, et al. Machine Learning-Based Fragment Selection Improves the Performance of Qualitative PRM Assays.Journal of proteome research, PubMed ID: 35849720
27, Xue Y, et al. Cardiopulmonary Injury in the Syrian Hamster Model of COVID-19.Viruses, PubMed ID: 35891384
28, Lee S, et al. PubMed ID: 36005818
29, Coler B, et al. Diminished Antiviral Innate Immune Gene Expression in the Placenta Following a Maternal SARS-CoV-2 Infection.American journal of obstetrics and gynecology, PubMed ID: 36126729
30, Khan M, et al. Anatomical barriers against SARS-CoV-2 neuroinvasion at vulnerable interfaces visualized in deceased COVID-19 patients.Neuron, PubMed ID: 36446381
31, Lindqvist R, et al. A Syntenin Inhibitor Blocks Endosomal Entry of SARS-CoV-2 and a Panel of RNA Viruses.Viruses, PubMed ID: 36298757
32, Chen M, et al. PubMed ID: 36494057
33, Que H, et al. PubMed ID: 36566328
34, Wang Y, et al. Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5.Cell discovery, PubMed ID: 36609558
35, Higashi-Kuwata N, et al. Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.Nature communications, PubMed ID: 36841831
36, Emmi A, et al. Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei.NPJ Parkinson's disease, PubMed ID: 36781876
37, Massimo M, et al. Haemorrhage of human foetal cortex associated with SARS-CoV-2 infection.Brain : a journal of neurology, PubMed ID: 36642091
38, Qiu S, et al. Successful clearance of persistent SARS-CoV-2 asymptomatic infection following a single dose of Ad5-nCoV vaccine.Signal transduction and targeted therapy, PubMed ID: 36922500
39, Nchioua R, et al. Reduced replication but increased interferon resistance of SARS-CoV-2 Omicron BA.1.Life science alliance, PubMed ID: 36977594
40, Dickey TH, et al. Design of a stabilized RBD enables potently neutralizing SARS-CoV-2 single-component nanoparticle vaccines.Cell reports, PubMed ID: 36943870
41, Alhammad YM, et al. SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in mice.bioRxiv : the preprint server for biology, PubMed ID: 37066301
42, Byström JW, et al. At-home sampling to meet geographical challenges for serological assessment of SARS-CoV-2 exposure in a rural region of northern Sweden, March to May 2021: a retrospective cohort study.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, PubMed ID: 36995373
43, Yue M, et al. Coronaviral ORF6 protein mediates inter-organelle contacts and modulates host cell lipid flux for virus production.The EMBO journal, PubMed ID: 37218505
44, Van Slambrouck J, et al. Visualising SARS-CoV-2 infection of the lung in deceased COVID-19 patients.EBioMedicine, PubMed ID: 37224768
45, Min YQ, et al. A new cellular interactome of SARS-CoV-2 nucleocapsid protein and its biological implications.Molecular & cellular proteomics : MCP, PubMed ID: 37211047
46, Burnap SA, et al. Cross-linking Mass Spectrometry Uncovers Interactions Between High-density Lipoproteins and the SARS-CoV-2 Spike Glycoprotein.Molecular & cellular proteomics : MCP, PubMed ID: 37343697
47, Alhammad YM, et al. SARS-CoV-2 Mac1 is required for IFN antagonism and efficient virus replication in cell culture and in mice.Proceedings of the National Academy of Sciences of the United States of America, PubMed ID: 37607224
48, Addetia A, et al. Neutralization, effector function and immune imprinting of Omicron variants.Nature, PubMed ID: 37648855
49, Hirata Y, et al. Genomic analysis of SARS-CoV-2 in forensic autopsy cases of COVID-19.Journal of medical virology, PubMed ID: 37537838
50, Ford ES, et al. Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8+ T cells in persons with previous COVID-19.Nature immunology, PubMed ID: 38057617
51, Sasaki M, et al. Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster model.EBioMedicine, PubMed ID: 38159532
52, Garvanska DH, et al. The NSP3 protein of SARS-CoV-2 binds fragile X mental retardation proteins to disrupt UBAP2L interactions.EMBO reports, PubMed ID: 38177924
53, Uraki R, et al. An mRNA vaccine encoding the SARS-CoV-2 receptor-binding domain protects mice from various Omicron variants.NPJ vaccines, PubMed ID: 38167505
54, Yang L, et al. SARS-CoV-2 infection causes dopaminergic neuron senescence.Cell stem cell, PubMed ID: 38237586
55, Nagasawa S, et al. Changes in SARS-CoV-2 viral load and titers over time in SARS-CoV-2-infected human corpses.PloS one, PubMed ID: 38536820
56, Wang W, et al. Digital Surface-Enhanced Raman Spectroscopy-Lateral Flow Test Dipstick: Ultrasensitive, Rapid Virus Quantification in Environmental Dust.Environmental science & technology, PubMed ID: 38452107
57, Du H, et al. PubMed ID: 38447818
58, Jeong GU, et al. Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis.Experimental & molecular medicine, PubMed ID: 38816566
59, Liu B, et al. An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike.Cell reports, PubMed ID: 38805396
60, Komiya Y, et al. Necroptosis in alveolar epithelial cells drives lung inflammation and injury caused by SARS-CoV-2 infection.Biochimica et biophysica acta. Molecular basis of disease, PubMed ID: 39154794
61, Yabu H, et al. Janus-Type Immunofluorescent Probes and a Quantitative Immunoassay System.Langmuir : the ACS journal of surfaces and colloids, PubMed ID: 39145991